What type of study is this?

This is a In Vitro Study study.

December 8, 2025Blood

Multi-omics reveals immune features in immune and non-immune cells, an IFN-γ/IFN-α-B2M positive feedback loop, and targeted metabolic therapy in multiple myeloma

View Full Paper

Ask AI

Bookmark

Authors

Multi-omics approach reveals immune checkpoint molecules and a feedback loop in multiple myeloma, highlighting potential therapies.

Immune checkpoint molecules were identified in novel immune subpopulations, indicating important roles in tumor microenvironment dynamics.
Data analysis revealed a feedback loop involving immune factors that contribute to disease progression in multiple myeloma.
Assessment using single-cell RNA sequencing and metabolic profiling enabled insights into immune evasion mechanisms.
Increased understanding of tumor microenvironment dynamics may inform future targeted metabolic therapy interventions.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

Authors

Multi-omics approach reveals immune checkpoint molecules and a feedback loop in multiple myeloma, highlighting potential therapies.

Immune checkpoint molecules were identified in novel immune subpopulations, indicating important roles in tumor microenvironment dynamics.
Data analysis revealed a feedback loop involving immune factors that contribute to disease progression in multiple myeloma.
Assessment using single-cell RNA sequencing and metabolic profiling enabled insights into immune evasion mechanisms.
Increased understanding of tumor microenvironment dynamics may inform future targeted metabolic therapy interventions.

Li et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark